Results of liquid biopsy studies by next generation sequencing in patients with advanced stage non-small cell lung cancer: Single center experience from Turkey

Results of liquid biopsy studies by next generation sequencing in patients with advanced stage non-small cell lung cancer: Single center experience from Turkey

Several studies demonstrated the utility of plasma-based cell-free circulating tumor DNA (ccfDNA) in determination of mutations in non-small cell lung cancer (NSCLC). We aimed to report our results of next generation sequencing (NGS) using liquid biopsy in patients with NSCLC. Patients with advanced...

Full description

Bibliographic Details
Main Authors: Buyuksimsek M, Togun M, Oguz Kara I, Bisgin A, Boga I, Tohumcuoglu M, Ogul A, Evren Yetisir A, Sahin B, Sumbul HE, Mirili C
Format: Article
Language:English
Published: Sciendo 2019-12-01
Series:Balkan Journal of Medical Genetics
Subjects:
liquid biopsy
new generation sequencing (ngs)
non-small cell lung cancer (nsclc)
Online Access:https://doi.org/10.2478/bjmg-2019-0016

Internet

https://doi.org/10.2478/bjmg-2019-0016

Similar Items